메뉴 건너뛰기




Volumn 183, Issue 1, 2002, Pages 2-3

Treatment of Helicobacter pylori infection in patients with peptic ulcer disease

Author keywords

Antimicrobial; Drug costs; Helicobacter pylori; Peptic ulcer

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BISMUTH; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; RANITIDINE; RANITIDINE BISMUTH CITRATE; STOMACH SECRETION INHIBITOR; TETRACYCLINE;

EID: 0036177285     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(01)00853-4     Document Type: Article
Times cited : (6)

References (8)
  • 2
    • 0030064351 scopus 로고    scopus 로고
    • The influence of drug dosage on Helicobacter pylori eradication: A cost-effectiveness analysis
    • (1996) Am J Gastroenterol , vol.91 , pp. 246-257
    • Treiber, G.1
  • 4
    • 0007429598 scopus 로고    scopus 로고
    • Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology
    • (1998) Am J Gastroenterol , vol.93 , pp. 2330-2338
    • Howden, C.W.1    Hunt, R.H.2
  • 5
  • 7
    • 0032056306 scopus 로고    scopus 로고
    • Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: A randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens
    • (1998) Am J Gastroenterol , vol.93 , pp. 584-590
    • Schwartz, H.1    Krause, R.2    Sahba, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.